Association of Antidepressant Medications With Incident Type 2 Diabetes Among Medicaid-Insured Youths-Reference-Cited by-同舟云学术

Association of Antidepressant Medications With Incident Type 2 Diabetes Among Medicaid-Insured Youths

Published:2017-12-01 Issue:12 Volume:171 Page:1200
ISSN:2168-6203
Container-title:JAMA Pediatrics
language:en
Short-container-title:JAMA Pediatr

Author:

Burcu Mehmet¹,Zito Julie M.²,Safer Daniel J.³,Magder Laurence S.⁴,dosReis Susan¹,Shaya Fadia T.¹,Rosenthal Geoffrey L.⁵

Affiliation:

1. Department of Pharmaceutical Health Services Research, University of Maryland, Baltimore

2. Department of Pharmaceutical Health Services Research, University of Maryland, Baltimore2Department of Psychiatry, University of Maryland, Baltimore

3. Department of Pediatrics, Johns Hopkins Medical Institutions, Baltimore, Maryland4Department of Psychiatry, Johns Hopkins Medical Institutions, Baltimore, Maryland

4. Department of Epidemiology and Public Health, University of Maryland, Baltimore

5. Department of Epidemiology and Public Health, University of Maryland, Baltimore6Department of Pediatrics, University of Maryland, Baltimore

Publisher

American Medical Association (AMA)

Subject

Pediatrics, Perinatology, and Child Health

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incident diabetes in adolescents using antidepressant: a systematic review and meta-analysis;European Child & Adolescent Psychiatry;2024-06-24

2. Prescription medication use among patients with type 2 diabetes in the United States: 1999–2020;Diabetes, Obesity and Metabolism;2024-05-02

3. Insulin Impairment Disrupts Central Serotonin Synthesis: Implications for Stress Resilience;Serotonin - Neurotransmitter and Hormone of Brain, Bowels and Blood;2024-01-18

4. Perspectives on ADHD in children and adolescents as a social construct amidst rising prevalence of diagnosis and medication use;Frontiers in Psychiatry;2024-01-05

5. Neurological and metabolic related pathophysiologies and treatment of comorbid diabetes with depression;CNS Neuroscience & Therapeutics;2023-11-06